Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;22(6):745-747.
doi: 10.1016/S1473-3099(22)00207-9. Epub 2022 Apr 1.

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world

Affiliations
Comment

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world

Pramod Kumar Garg et al. Lancet Infect Dis. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Kojima N, Klausner JD. Protective immunity after recovery from SARS-CoV-2 infection. Lancet Infect Dis. 2022;22:12–14. - PMC - PubMed
    1. Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J. 2021 doi: 10.1136/postgradmedj-2021-140654. published online Aug 5. - DOI - PubMed
    1. Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23:186–193. - PubMed
    1. Kannenberg J, Trawinski H, Henschler R, Buhmann R, Hönemann M, Jassoy C. Antibody course and memory B-cell response in the first year after SARS-CoV-2 infection. J Infect Dis. 2022 doi: 10.1093/infdis/jiac034. published online Feb 1. - DOI - PMC - PubMed
    1. Cerqueira-Silva T, Andrews JR, Boaventura VS, et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00140-2. published March 31. - DOI - PMC - PubMed

Substances